Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

Christopher A Maher

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9035-603X; OpenAlex author ID A5028616783; NIH RePORTER profile ID 9231962. Sources: OpenAlex.

Their work

Papers
1 (first author 0, last author 1)
Trials
0
Grants
3
Labs led
1
Collaborators
5
Papers, trials and grants by year

2011: 1 grant · 2012: none · 2013: 1 grant · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 grant

Papers 1

  1. Single-cell transcriptomics reveals long noncoding RNAs associated with tumor biology and the microenvironment in pancreatic cancer. Last author DOI 10.1093/narcan/zcad055↗

Grants 3

  1. 11 Solid Tumor Therapeutics Program P30CA091842↗
  2. Characterization of Cancer Transcriptomes using Next Generation Sequencing R00CA149182↗
  3. Characterization of Cancer Transcriptomes using Next Generation Sequencing K99CA149182↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Timothy J. Eberlein · 1 shared grant, 2026 · strength 1.00
  2. Reid Townsend · 1 shared grant, 2026 · strength 1.00
  3. Ha X. Dang · 1 shared paper, 2023 · strength 0.18
  4. Li Ding · 1 shared paper, 2023 · strength 0.18
  5. Ryan C Fields · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.